Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SEMAGLUTIDE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where SEMAGLUTIDE was used for Psoriasis.

Most Reported Side Effects for SEMAGLUTIDE

Side Effect Reports % Deaths Hosp.
Nausea 10,036 16.8% 67 2,069
Vomiting 6,518 10.9% 58 2,092
Off label use 5,425 9.1% 30 1,095
Diarrhoea 5,331 8.9% 42 1,392
Decreased appetite 4,317 7.2% 35 917
Constipation 4,036 6.8% 14 937
Weight decreased 3,518 5.9% 39 514
Impaired gastric emptying 2,622 4.4% 12 1,483
Product use in unapproved indication 2,613 4.4% 31 440
Wrong technique in product usage process 2,538 4.3% 4 150
Abdominal pain upper 2,503 4.2% 15 571
Headache 2,432 4.1% 12 259
Blood glucose increased 2,240 3.8% 15 284
Fatigue 2,196 3.7% 10 298
Inappropriate schedule of product administration 2,139 3.6% 14 396

Other Indications for SEMAGLUTIDE

Product used for unknown indication (24,996) Type 2 diabetes mellitus (17,910) Weight control (6,378) Diabetes mellitus (4,265) Obesity (2,586) Weight decreased (1,680) Glucose tolerance impaired (1,475) Overweight (497) Type 1 diabetes mellitus (245) Glycosylated haemoglobin increased (229)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

SEMAGLUTIDE Full Profile All Psoriasis Drugs SEMAGLUTIDE Demographics SEMAGLUTIDE Timeline